 influenc chemotherapi administr monocyt activ liposom muramyl phosphatidylethanolamin children osteosarcoma purpos studi chemotherapi abil peripher blood monocyt patient osteosarcoma liposome-encapsul activ agent muramyl tripeptid phosphatidylethanolamin l-mtp-pe prepar adjuv therapi protocol l-mtp-pe chemotherapi treatment primari osteosarcoma major patient current adjuv chemotherapi chemotherapi import l-mtp-pe chemotherapi treatment cours chemotherapi cycl tumoricid properti monocyt patient osteosarcoma l-mtp-pe level equal normal control monocyt intrins monocyt defect single-ag chemotherapi consist cisplatin cpd high-dos methotrex mtx cytoxan ctx cyclophosphamid bristol-my Co evansvil IN adriamycin adr doxorubicin adria columbu OH activ process suggest enhanc activ potenti administr adr adr ctx day profound suppress monocyt activ suppress function normal week postcombin therapi l-mtp-pe adr cpd mtx ctx singl agent adr l-mtp-pe effect combin contrast use l-mtp-pe adr ctx